xwzx

NEWS

TEL
Microban International announces new range of antiviral technologies
<p style="text-align: center;"><img src="/ueditor/php/upload/image/20211111/1636616587124680.png" title="1636616587124680.png" alt="9.png"/></p><p>Microban International announced a new range of antiviral technologies that are proven to reduce viral loading on products and surfaces.</p><p><br/></p><p>Microban&nbsp;technology can be incorporated into various materials during manufacturing, becoming part of the product¡¯s structure to provide inherent and enduring protection from microbes.</p><p><br/></p><p>Recent data demonstrates that new antiviral technologies from Microban conform to both ISO 18184 ¨C which assesses the antiviral performance of treated textile products, such as woven and knitted fabrics, fibres, yarns, and braids ¨C and ISO 21702, which measures activity in treated plastics and other non-porous surfaces.</p><p><br/></p><p>Testing was performed to evaluate the efficacy of each product type against many viruses, including bacteriophage Phi6, an important surrogate virus for SARS-CoV-2. The results showed that articles treated with these technologies can now benefit from reduced viral loading by up to 99 per cent.</p><p><br/></p><p>Antiviral technologies from Microban inhibit the viruses¡¯ ability to remain viable on surfaces. The modes of action vary, disrupting the structure of either the outer protein coat ¨C to prevent viruses from recognizing or binding to host cells ¨C or nucleic acid payload, to prevent viral replication.</p><p><br/></p><p>¡°We are excited with the latest results confirming the antiviral activity of our new technologies. Assessing antiviral efficacy in treated products to a standard that meets the complex regulatory landscape is an arduous process, but we have been confident throughout that our innovative solutions&nbsp;conformed to the rigorous ISO standards,¡± said Michael Ruby, President, Microban International. ¡°Our world-class research team and global in-house regulatory department worked diligently to ensure that the technology is recognised as effective and compliant across various markets, to support partners with their&nbsp;claims and give customers even greater confidence in products protected with Microban antiviral technology.¡±</p><p><br/></p>
11 Nov,2021
Naqi Trading Singapore Pte Ltd.
Naqi Trading Singapore Pte Ltd.     Copyright 2012-2016
Tel£º+65 97728133      Fax£º+65 62421009
Email£ºshrrd111@163.com   
Website£ºwww.nqbearing.com
Address£º111, North Bridge Road, #21-01. Peninsula Plaza. Singapore 179098.
»¦ICP±¸16043139ºÅ-1    
ÊÖ»úÍøÕ¾
Mobile Site